Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study

Autor: Nikki van Leeuwen, Mengmeng Du, Iris Lansdorp-Vogelaar, Ann G. Zauber, Ewout W. Steyerberg, Elisabeth F. P. Peterse, Maaike Alblas
Přispěvatelé: Public Health
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Cancer Research
medicine.medical_specialty
Cost effectiveness
Colorectal cancer
medicine.medical_treatment
Cost-Benefit Analysis
03 medical and health sciences
0302 clinical medicine
Quality of life
SDG 3 - Good Health and Well-being
lynch syndrome
Atypia
Medicine
Humans
Radiology
Nuclear Medicine and imaging

advisory committees
030212 general & internal medicine
hysterectomy
theoretical
cost-effectiveness
Research Articles
RC254-282
Aged
Aged
80 and over

Hysterectomy
business.industry
Obstetrics
Endometrial cancer
microsimulation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
cost‐effectiveness
Middle Aged
medicine.disease
Colorectal Neoplasms
Hereditary Nonpolyposis

Lynch syndrome
United States
3. Good health
Oncology
030220 oncology & carcinogenesis
Cohort
Quality of Life
Female
microsimulation model
business
Cancer Prevention
Research Article
Zdroj: Cancer Medicine, Vol 10, Iss 19, Pp 6835-6844 (2021)
Cancer Medicine
Cancer Medicine, 10(19), 6835-6844. WILEY
Cancer Medicine, 10(19), 6835-6844. John Wiley & Sons Ltd.
ISSN: 2045-7634
Popis: Background To evaluate the cost‐effectiveness of prophylactic hysterectomy (PH) in women with Lynch syndrome (LS). Methods We developed a microsimulation model incorporating the natural history for the development of hyperplasia with and without atypia into endometrial cancer (EC) based on the MISCAN‐framework. We simulated women identified as first‐degree relatives (FDR) with LS of colorectal cancer patients after universal testing for LS. We estimated costs and benefits of offering this cohort PH, accounting for reduced quality of life after PH and for having EC. Three minimum ages (30/35/40) and three maximum ages (70/75/80) were compared to no PH. Results In the absence of PH, the estimated number of EC cases was 300 per 1,000 women with LS. Total associated costs for treatment of EC were $5.9 million. Offering PH to FDRs aged 40–80 years was considered optimal. This strategy reduced the number of endometrial cancer cases to 5.4 (−98%), resulting in 516 quality‐adjusted life years (QALY) gained and increasing the costs (treatment of endometrial cancer and PH) to $15.0 million (+154%) per 1,000 women. PH from earlier ages was more costly and resulted in fewer QALYs, although this finding was sensitive to disutility for PH. Conclusions Offering PH to 40‐ to 80‐year‐old women with LS is expected to add 0.5 QALY per person at acceptable costs. Women may decide to have PH at a younger age, depending on their individual disutility for PH and premature menopause.
We evaluated the cost‐effectiveness of prophylactic hysterectomy (PH) in women with Lynch syndrome (LS). Offering PH to 40–80 year old women with LS is expected to add 0.5 QALY per person at acceptable costs. Women may decide to have PH at age 35 years, depending on their individual disutility for PH and premature menopause.
Databáze: OpenAIRE